Skip to main content

Back to all insights


Why Payers Don’t Really Control the Drug Benefit — and Why They Need to

January 10, 2013

What role does the purchase and management of drugs play in the transformation from a fee-for-service economy to a world of financial tradeoffs? This piece explores a few of the strategies being employed today and highlights RxAnte as an approach to improving Star Ratings. Visit here to read the whole story.